CAS: 56050-05-6 - Estra-1,3,5(10),7-tetraene-3,17-diol, 3-(hydrogen sulfate), monosodium salt, (17α)-
Fórmula:C18H21NaO5S
InChI:InChI=1S/C18H22O5S.Na/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19;/h3-5,10,14,16-17,19H,2,6-9H2,1H3,(H,20,21,22);/t14-,16+,17-,18+;/m1./s1
Chave InChI:InChIKey=SFYNEMQDUODPIF-AMGVKYAUSA-N
SMILES:[Na].O=S(=O)(O)OC1=CC=C2C(=C1)CC=C3C2CCC4(C)C(O)CCC34
- Sinónimos:
- 17alpha-Dihydroequilin sodium 3-sulfate
- 17alpha-Hydroxyestra-1,3,5(10),7-tetraen-3-yl sodium sulfate
- 17α-Dihydroequilin sodium sulfate
- Estra-1,3,5(10),7-tetraene-3,17-diol, 3-(hydrogen sulfate), monosodium salt, (17alpha)-
- Estra-1,3,5(10),7-tetraene-3,17-diol, 3-(hydrogen sulfate), sodium salt (1:1), (17α)-
- Sodium (9Xi,14Xi,17Alpha)-3-(Sulfooxy)Estra-1,3,5(10),7-Tetraen-17-Olate
- α-Equilol sodium sulfate
Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
---|---|---|---|---|
17a-Dihydro Equilin 3-Sulfate Sodium Salt REF: 4Z-E-3014CAS: 56050-05-6 | - - - | A consultar | Ter 10 Dez 24 | |
Sodium 17α-dihydroequilin sulfate REF: 3D-FS181983CAS: 56050-05-6 | Min. 95% | A consultar | Ter 10 Dez 24 | |
17alpha-Dihydro Equilin 3-Sulfate Sodium Salt (Stabilized with TRIS, 50% w/w) REF: TR-D498480CAS: 56050-05-6 | - - - | 9.065,00 € | Qui 09 Jan 25 | |
17α-Dihydro equilin 3-sulfate sodium salt REF: 3D-GCA05005CAS: 56050-05-6 | Min. 95% | - - - | Produto descontinuado |
17a-Dihydro Equilin 3-Sulfate Sodium Salt
Ref: 4Z-E-3014
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Sodium 17α-dihydroequilin sulfate
Ref: 3D-FS181983
Tamanho indefinido | A consultar |
17alpha-Dihydro Equilin 3-Sulfate Sodium Salt (Stabilized with TRIS, 50% w/w)
Produto ControladoRef: TR-D498480
100mg | 9.065,00 € |
17α-Dihydro equilin 3-sulfate sodium salt
Ref: 3D-GCA05005
1mg | Descontinuado | Solicitar informações | |
5mg | Descontinuado | Solicitar informações | |
10mg | Descontinuado | Solicitar informações | |
25mg | Descontinuado | Solicitar informações |